Background. The treatment of uraemic patients with recombinant human erythropoietin (rHuEpo) often leads to an increase in blood pressure. Indirect and direct effects of the hormone are probably involved. We explored the possibility of a direct action on the vascular smooth muscle cell (VSMC). Methods. Rat VSMC were isolated from aortas of spontaneously hypertensive rats (SHR) and normotensive control rats (WKY) and maintained in culture. They were exposed to rHuEpo under various experimental conditions, and cells proliferative index was measured by [
Introduction
Erythropoietin is a 30.4-kDa polypeptide. It is synthesized in the kidney and regulates the proliferation, differentiation and survival of the erythroid progenitor cells [1, 2] . Recombinant human Epo is widely used for the treatment of anaemia in patients suffering from end-stage renal failure.
One of the main complications of this treatment is the development of hypertension or the aggravation of pre-existing hypertension which occurs in approximately 20-35% of hemodialysis patients [3, 4] . Several mechanisms have been proposed to explain the hypertension induced by the administration of rHuEpo to haemodialysis patients, including indirect and direct modes of action on the cardiovascular system.
Among indirect mechanisms, haemodynamic effects via the increase in haematocrit and accompanying blood viscosity, loss of hypoxic vasodilatation, and effects on the renin-angiotensin system, the peripheral sympathetic nervous system, and the central nervous system have all been suspected of playing a major role [3, 4] . Interferences with endothelium-derived contracting and relaxing factors have been reported as well [5, 6] .
As to direct mechanisms, experimental evidence has been provided in favour of both rapid and delayed modes of action. The recent demonstration by Anagnostou et al.[l] that the Epo receptor is expressed in vascular endothelial cells has given strong support to the hypothesis of a direct action on the vessel wall. A very rapid, direct enhancing effect of rHuEpo on VSMC contraction in isolated rat mesenteric and renal vessels first has been reported by Heidenreich et al. [8] . However, hormone concentrations used in the incubation medium were extremely high. Such direct effects in vitro could not be confirmed by others at the level of isolated human blood vessels [9] . A rapid rHuEpo effect on blood pressure has been claimed to occur in haemodialysis patients [10] . However, we were unable to confirm this observation [11] . It was therefore tempting to explore the possibility of more delayed, direct effects of rHuEpo on the vasculature. We have recently demonstrated a stimulatory effect of the hormone on rat VSMC [ 3 H]-thymidine incorporation in vitro, involving enhanced expression of protooncogenes and a stimulation of phospholipase C activity [12] . Other investigators have shown an enhancing effect on angiogenesis in vitro [13] . 688 The purpose of the present work was to explore further the mechanisms involved in the direct Epo effect on rat VSMC proliferation. We asked in particular whether Epo might act on VSMC through a specific EpoR.
Materials and methods

Cell culture systems
Aortas were isolated from 10-week-old male SHR and WKY rats. Primary cultures of VSMC were established as described by Ross [14] . Cells were then cultured in RPMI 1640 supplemented with 2 mM glutamine, lOOU/ml penicillin, lOOug/ml streptomycin, and 10% fetal calf serum (FCS), and passaged at confluence once a week.
Reds cells [15] were grown in modified Eagle's medium (MEM) containing 10% FCS. The cells were maintained by reseeding every 3-4 days.
DNA synthesis
The rate of DNA synthesis induced by rHuEpo (Recormon, Boehringer Laboratory, Mannheim, Germany) was examined by the incorporation of [ Cells were cultured in 24-well plates (2 x 10 4 cells/well) for 3 days, and then made quiescent by incubation in serum-free medium for 2 days. They were exposed for 24 h to rHuEpo or vehicle, in the absence or presence of 0.1 or 1% FCS in RPMI-1640 containing 1 uM thymidine and 0.5 uCi/ml [ 3 H]-thymidine. Various concentrations of rHuEpo were tested. Experiments were run in parallel with 10% FCS as positive controls. Thereafter, medium was removed and cells were washed by 1 ml/well ice-cold PBS. The determination of radioactivity was performed essentially as described by Zhu et al. [16] . Results have been expressed as -fold stimulation, by the ratio of c.p.m. in stimulated cells to c.p.m. in controls.
Northern blots
VSMC (10 6 cells) were first cultured in 75-cm 2 flasks in medium supplemented with 10% FCS for 2-3 days until subconfluence. SHR VSMC were made quiescentes by 2 days incubation in serum-free medium, and then exposed to a rHuEpo dose-dependent stimulation for 24 h, or to 10 U/ml rHuEpo in time course stimulation. RNA of non-stimulated VSMC from WKY rats was also examined. Reds cells were also exposed to a rHuEpo dose-dependent stimulation for 24 h, or to 1 U/ml rHuEpo in time course experiments. Total RNA from SHR, WKY, and Reds cells was extracted by RNA NOW™ reagent (Biogentex, USA).
Twenty-five micrograms of total RNA were electrophoresed through a 1% agarose-2.2 M formaldehyde gel and transferred to a nitrocellulose membrane, using 10 x standard saline citrate (SSC:1.5M NaCl, 0.15 M sodium citrate, pH 7). The membranes were hybridized with the 32 P-labelled 0.5 kb cDNA of the murine EpoR purified from Puc 18 plasmid (kindly provided by Catherine Lacombe MD, INSERM Unit 152, Paris) [17] , and the 32 P-labelled 1.1 kb cDNA of the mouse p actin gene [18] .
The hybridization was carried out for 16 h at 42C in 50% formamide, 5xSSC, lxDenhardt's solution, 0.16 mM NaH 2 PO 4 . Membranes were washed twice in 2xSSC-0.1% SDS for lOmin at 25°C, and once in 0.5xSSC-0.1% SDS for 5 min at 55°C. The membranes were exposed to Kodak Biomax MR films for 6 days.
Southern blots
DNA was extracted from Reds cells, SHR, and WKY VSMC, as described by Blin et al. [19] . DNA samples (20 ug) were digested with BamHI, EcoRI, and Hindlll restriction enzymes. They were then electrophoresed through a 0.7% agarose gel and transferred to a nylon membrane using 6 x SSC. The membranes were hybridized with the 32 Plabelled 0.5 kb cDNA insert of the murine EpoR.
Results
Effect ofrHuEpo on DNA synthesis
Quiescent VSMC were exposed to rHuEpo either in serum-free culture medium, in culture medium containing 0.1% FCS, or in culture medium containing 1% FCS. Under each condition, control cells received vehicle treatment and were cultured in either serumfree, 0.1%, or 1% FCS-containing media respectively.
VSMC from WKY rats were not significantly stimulated by rHuEpo (data not shown). Conversely, while rHuEpo did not stimulate [ The increase in DNA synthesis in the presence of 1% FCS was significant when using rHuEpo at 16 and 64 U/ml. Maximal stimulation obtained with high rHuEpo concentrations in the incubation medium was 1.6-fold. Stimulation of DNA synthesis with 10% FCS as positive control, was 7-to 10-fold that of control (data not shown).
Expression of erythropoietin receptor mRNA in rat VSMC
Total RNAs from rat VSMC and mouse Reds cells were hybridized with EpoR cDNA insert. Figure 2 shows that in rat VSMC (SHR and WKY) the detected mRNA fragment appeared to be of slightly greater size than the Reds EpoR-specific mRNA. In Reds cells the EpoR mRNA detected was of approximately 2.1 kb weight, in accord with the murine EpoR described by Kuramochi et al. [20] .
SHR VSMC and Reds cells were exposed to rHuEpo in a dose-dependent manner for 24 h, whereas control cells were exposed to vehicle (0). Figure 3A shows that in SHR cells the hybridized mRNA was equally expressed at 0 and 0.1 U/ml but its level decreased at higher concentrations (5, 10 and 50 U/ml). In Reds cells ( Figure 3B ) the EpoR mRNA expression was similarly modulated by rHuEpo in a dose-dependent fashion.
In a time course experiment SHR VSMC and Reds cells were stimulated by rHuEpo with respectively 10 U/ml or 1 U/ml. As shown in Figure 4A , at the The RNA blotted to the filter was hybridized with 32 P-labelled mouse EpoR cDNA probe or to the 32 P-labeIIed mouse /? actin cDNA. This is a typical result of three experiments. Fig. 4 . Northern blot analysis of EpoR mRNA expression from cells stimulated by rHuEpo in a time course stimulation. (A) SHR VSMC were exposed to 10 U/ml of rHuEpo, whereas (B) Reds cells were exposed to 1 U/ml of rHuEpo at the indicated times. Total RNA was extracted, blotted and hybridized with 32 P-labelled mouse EpoR cDNA probe, or to the 32 P-labelled mouse /J actin cDNA. This is a typical result of three experiments. 0.5 h time point, EpoR mRNA expression in SHR cells was similar to that of control. Variable level of mRNA expression was observed at 1 and 6 h, whereas in Figure 4B the time course stimulation of Reds cells showed a different pattern of expression from that observed in SHR cells. EpoR mRNA level was increased 3 h after addition of rHuEpo, reached a peak at 6 h and returned towards the basal level at 24 h.
Under the experimental conditions used, the expression levels of P actin mRNA remained relatively constant throughout. 
EpoR genes in Reds cells and VSMC
To investigate the observed difference in the EpoR mRNA molecular weight between Reds cell and VSMC, the EpoR gene from both cells was examined by Southern-blot. The result showed ( Figure 5 ) that DNA hybridization pattern was identical between WKY and SHR VSMC, but differed from Reds cell pattern. This observation is in accord with the EpoR gene polymorphism between rats and mice and excludes the possibility of an EpoR gene rearrangement in VSMC.
Discussion
The present study confirms our previous finding of a stimulation by relatively high concentrations of rHuEpo of DNA synthesis by cultured VSMC derived from SHR aorta [12] . However, whereas in our previous experiments stimulation of DNA synthesis by VSMC was obtained even in the absence of FCS, in the present experiments the presence of FCS was required to obtain the rHuEpo effect. Our novel finding is the expression of EpoR mRNA in VSMC derived from SHR, and to a lesser extent also in VSMC derived from normotensive WKY control rats. The intensity of EpoR mRNA changed in response to increases of rHuEpo concentration and length of time of exposure to the hormone.
It has long been known that Epo increases RBC mass by enhancing the generation of red cell pre-F. Ammarguellat el al. cursors. In keeping with this, the Epo-dependent murine erythroleukaemia cell line, HCD-57 proliferates vigourosly at saturating concentrations of Epo in the presence of 5% FCS [21] . However, it has become clear only recently that the major action of Epo probably is not a stimulation of erythroid cell proliferation but the prevention of erythroid cell apoptosis [22] . Epo appears to require the concomitant presence of other growth factors such as IGF-1 and stem cell factor to exert its action on erythroid proliferation and maturation [22] . In keeping with this observation, the presence of FCS in the incubation media of our VSMC experiments might have allowed rHuEpo to act in a cooperative fashion with other serum-derived growth factors.
Whether Epo directly acts on vascular smooth muscle or not remains matter of controversy at present. Heidenreich et al. [8] showed that very high rHuEpo concentrations were able to elicit a contractile response in isolated blood vessels within 1 min after hormone addition to the incubation medium. This effect even was observed after removing vascular endothelium, indicating a direct rHuEpo effect on smooth muscle. Even though similar results were obtained by another group [23] , others were unable to observe a direct contractile effect of rHuEpo either in isolated rat [24] or human [9] blood vessels. Discrepant findings between these studies may be due to differences in experimental conditions, including varying blood vessel preparations, rHuEpo concentrations, and length of exposure to the hormone.
In the present experiments, an EpoR mRNA was detected in SHR and WKY VSMC. Therefore the stimulatory effects of rHuEpo on growth-related parameters in VSMC previously found by our group [12] and those reported in the present study could be explained by the expression of a specific EpoR in rat vascular smooth muscle. The transcript appeared to be slightly different from that obtained in Reds cells. We have at present no explanation for this difference. Further studies are clearly necessary to characterize this mRNA.
It must be pointed out that our repeated attempts to demonstrate specific rHuEpo binding to VSMC remained unsuccessful. In five binding experiments SHR VSMC were exposed to 125 I-labelled rHuEpo in culture medium containing 10% FCS, for different periods of time. A time-dependent increase of binding appeared to occur, but radioactivities counted were too small to allow any definite conclusion about a specific binding of rHuEpo to rat VSMC (data not shown). Our failure may have several explanations, including the following three: (1) low number of EpoR in cell membrane, (2) absence of receptors on the cell surface under our experimental conditions, and (3) rapid degradation of the internalized radioiodinated Epo bound to its receptor, and its release in the culture medium. First, it is well known that even on erythroid precursor cells the number of EpoR expressed at the cell surface is extremely low [25] . Second, Epo receptors regularly circle from the cell surface to the cyto- Epo receptor in vascular smooth muscle plasm, depending on various factors such as the ambient Epo concentration [26, 27] . In this regard it is possible that the Epo present in FCS binds to the cell EpoR, and therefore no available binding sites remain at the cell surface. Third, Sawyer et al. [28] reported that the internalized radiolabelled Epo is degraded, and the degradation products are released into the medium with a corresponding loss of label from the interior of the cell.
The recent finding by Anagnostou et al. [7] of an expression of the EpoR in human umbilical vein endothelium, together with the observation of a mitogenic effect of Epo on endothelial cells [5, 13, 29] and VSMC [12] strongly support direct actions of the hormone on non-erythroid cells, besides its main action on erythroid cells. During the last 3 years, effects of Epo in other non-haematological tissues have been reported by several groups, namely the nervous system [30] , the kidney [31, 32] , and the testes [33] , and specific binding sites for Epo have been characterized in mouse neuronal cells in culture [34] and in defined areas of mouse brain [35] .
The vascular mitogenic effect of Epo could be mediated by an action on endothelin-1 release by the vascular endothelium, as proposed by Carlini et al. [5, 13] or by a direct effect on VSMC, as proposed by us. Obviously, the two modes of action are not mutually exclusive.
We used mainly VSMC from SHR since VSMC from WKY were generally less responsive or even unresponsive to Epo stimulation in terms of { 3 H}-thymidine incorporation. This is in accord with the recent report by Tsukada et al. [23] , where rHuEpo exhibited a direct vasopressor effect preferentially in blood vessels derived from SHR. Interestingly, the authors of another study found in uraemic patients that a genetic predisposition might favour the development of high blood pressure in response to rHuEpo [36] ,
In conclusion, the present report provides preliminary evidence in favour of a direct action of Epo on SHR vasculature via a specific Epo receptor expressed in vascular smooth muscle.
